Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors,Thoracic Cancer

当前位置： X-MOL 学术 › Thorac. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
Thoracic Cancer ( IF 2.3 ) Pub Date : 2023-03-16 , DOI: 10.1111/1759-7714.14847
Chunwei Xu _{1,

2,

3} , Yongchang Zhang ₄ , Wenxian Wang ₂ , Qian Wang ₅ , Ziming Li ₆ , Zhengbo Song ₂ , Jiandong Wang ₇ , Jinpu Yu ₈ , Jingjing Liu ₉ , Shirong Zhang ₁₀ , Xiuyu Cai ₁₁ , Ming Wu ₁₂ , Ping Zhan ₃ , Hongbing Liu ₃ , Tangfeng Lv ₃ , Liyun Miao ₁₃ , Lingfeng Min ₁₄ , Jiancheng Li ₁₅ , Baogang Liu ₁₆ , Jingping Yuan ₁₇ , Zhansheng Jiang ₁₈ , Gen Lin ₁₉ , Xiaohui Chen ₂₀ , Xingxiang Pu ₂₁ , Chuangzhou Rao ₂₂ , Dongqing Lv ₂₃ , Zongyang Yu ₂₄ , Xiaoyan Li ₂₅ , Chuanhao Tang ₂₆ , Chengzhi Zhou ₂₇ , Junping Zhang ₂₈ , Hui Guo ₂₉ , Qian Chu ₃₀ , Rui Meng ₃₁ , Xuewen Liu ₃₂ , Jingxun Wu ₃₃ , Xiao Hu ₃₄ , Min Fang ₃₄ , Jin Zhou ₃₅ , Zhengfei Zhu ₃₆ , Xiaofeng Chen ₃₇ , Weiwei Pan ₃₈ , Fei Pang ₃₉ , Yuxiang Zhou ₃₉ , Qijie Jian ₃₉ , Kai Wang ₃₉ , Liping Wang ₄₀ , Youcai Zhu ₄₁ , Guocai Yang ₄₂ , Xinqing Lin ₂₇ , Jing Cai ₄₃ , Lijun Liang ₁₂ , Huijing Feng ₂₈ , Lin Wang ₄₄ , Yingying Du ₄₅ , Wang Yao ₄₆ , Xuefei Shi ₄₇ , Xiaomin Niu ₆ , Dongmei Yuan ₃ , Yanwen Yao ₃ , Jianhui Huang ₄₈ , Yinbin Zhang ₄₉ , Pingli Sun ₅₀ , Hong Wang ₅₁ , Mingxiang Ye ₃ , Dong Wang ₃ , Zhaofeng Wang ₃ , Yue Hao ₂ , Zhen Wang ₅₂ , Bing Wan ₅₃ , Donglai Lv ₅₄ , Genhua Yu ₅₅ , Anna Li ₅₆ , Jin Kang ₅₆ , Jiatao Zhang ₅₆ , Chao Zhang ₅₆ , Huafei Chen ₄₁ , Lin Shi ₅₇ , Leiguang Ye ₁₆ , Gaoming Wang ₅₈ , Yina Wang ₅₉ , Feng Gao ₆₀ , Wei Zhou ₁ , Chunxiu Hu ₆₁ , Jianguo Wei ₆₂ , Bihui Li ₆₃ , Zhongwu Li ₆₄ , Yuan Li ₆₅ , Zhefeng Liu ₅₁ , Nong Yang ₃ , Lin Wu ₂₁ , Qiming Wang ₆₆ , Wenbin Huang ₆₇ , Zhuan Hong ₆₈ , Guansong Wang ₆₉ , Meiyu Fang ₄ , Yong Fang ₇₀ , Xixu Zhu ₅₂ , Kaiqi Du ₄₁ , Jiansong Ji ₇₁ , Yi Shen ₇₂ , Yiping Zhang ₄ , Shenglin Ma ₇₃ , Yong Song ₃ , Yuanzhi Lu ₇₄ , Anwen Liu ₄₃ , Wenfeng Fang ₇₅ , Wenzhao Zhong ₅₆

Affiliation

Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China.
Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.
Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Department of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Department of Thoracic Cancer, Jilin Cancer Hospital, Jilin, People's Republic of China.
Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Department of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Department of Thoracic Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, People's Republic of China.
Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, People's Republic of China.
Department of Radiation Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Derpartment of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Department of Medical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Department of Thoracic Surgery, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Department of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.
Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, People's Republic of China.
Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, People's Republic of China.
Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China.
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China.
Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Department of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, People's Republic of China.
Zhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China.
Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Department of Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China.
Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, People's Republic of China.
Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China.
Department of Oncology, Baotou Cancer Hospital, Baotou, People's Republic of China.
Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.
Department of Thoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhejiang, People's Republic of China.
Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China.
Department of Oncology, Lishui Municipal Central Hospital, Lishui, People's Republic of China.
Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Department of Pathology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Department of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Department of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, People's Republic of China.
Department of Radiation Oncology, Zhebei Mingzhou Hospital, Huzhou, People's Republic of China.
Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China.
Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, People's Republic of China.
Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Department of Cancer Radiotherapy and Chemotherapy, Zhejiang Queue Hospital, Quzhou, People's Republic of China.
Department of Pahtology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, People's Republic of China.
Department of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Department of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, People's Republic of China.
Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, People's Republic of China.
Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China.
Department of Radiology, Lishui Municipal Central Hospital, Lishui, People's Republic of China.
Department of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Department of Clinical Pathology, The First Affiliated Hospital Of Jinan University, Guangzhou, People's Republic of China.
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.

Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow-up of TETs.

更新日期：2023-03-16

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11